Hälsa & medicin
5.6
Nordic Study Quantifies Heart Inflammation Risk After mRNA COVID Vaccines
Researchers tracking millions of patients across four Nordic countries have documented clinical outcomes of myocarditis—inflammation of the heart muscle—following mRNA vaccination. The findings provide health authorities and insurers with population-level evidence to refine risk communication and monitoring protocols for post-vaccination cardiac events.
Originaltitel: Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study